Testing considerations for phosphatidylinositol‐3‐kinase catalytic subunit alpha as an emerging biomarker in advanced breast cancer

per Toppmeyer, Deborah L., Press, Michael F.
Publicat a Cancer Med (2020)

Decisional conflict among breast cancer patients considering contralateral prophylactic mastectomy

per Manne, Sharon, Smith, Barbara, Mitarotondo, Anna, Frederick, Sara, Toppmeyer, Deborah, Kirstein, Laurie
Publicat a Patient Educ Couns (2018)

Clinical and Pharmacologic Differences of CDK4/6 Inhibitors in Breast Cancer

per George, Mridula A., Qureshi, Sadaf, Omene, Coral, Toppmeyer, Deborah L., Ganesan, Shridar
Publicat a Front Oncol (2021)

Acute Cardiotoxicity With Concurrent Trastuzumab and Hypofractionated Radiation Therapy in Breast Cancer Patients

per Sayan, Mutlay, Abou Yehia, Zeinab, Gupta, Apar, Toppmeyer, Deborah, Ohri, Nisha, Haffty, Bruce G.
Publicat a Front Oncol (2019)

Identification of the YES1 Kinase as a Therapeutic Target in Basal-Like Breast Cancers

per Bilal, Erhan, Alexe, Gabriela, Yao, Ming, Cong, Lei, Kulkarni, Atul, Ginjala, Vasudeva, Toppmeyer, Deborah, Ganesan, Shridar, Bhanot, Gyan
Publicat 2010

Serum Biomarkers for the Detection of Cardiac Toxicity after Chemotherapy and Radiation Therapy in Breast Cancer Patients

per Tian, Sibo, Hirshfield, Kim M., Jabbour, Salma K., Toppmeyer, Deborah, Haffty, Bruce G., Khan, Atif J., Goyal, Sharad
Publicat 2014

A genetic variant in a PP2A regulatory subunit encoded by the PPP2R2B gene associates with altered breast cancer risk and recurrence

per Vazquez, Alexei, Kulkarni, Diptee, Grochola, Lukasz F., Bond, Gareth L., Barnard, Nicola, Toppmeyer, Deborah, Levine, Arnold J., Hirshfield, Kim M.
Publicat 2011

Polymorphic variants in TSC1 and TSC2 and their association with breast cancer phenotypes

per Mehta, Madhura S., Vazquez, Alexei, Kulkarni, Diptee A., Kerrigan, John E., Atwal, Gurinder, Metsugi, Shoichi, Toppmeyer, Deborah L., Levine, Arnold J., Hirshfield, Kim M.
Publicat 2010

A polymorphic variant in human MDM4 associates with accelerated age of onset of estrogen receptor negative breast cancer

per Kulkarni, Diptee A., Vazquez, Alexei, Haffty, Bruce G., Bandera, Elisa V., Hu, Wenwei, Sun, Yvonne Y., Toppmeyer, Deborah L., Levine, Arnold J., Hirshfield, Kim M.
Publicat 2009

5-Year Update of a Multi-Institution, Prospective Phase 2 Hypofractionated Postmastectomy Radiation Therapy Trial

per Poppe, Matthew M., Yehia, Zeinab A., Baker, Christopher, Goyal, Sharad, Toppmeyer, Deborah, Kirstein, Laurie, Chen, Chunxia, Moore, D.F., Haffty, Bruce G., Khan, Atif J.
Publicat a Int J Radiat Oncol Biol Phys (2020)

Breast-Conservation Therapy after Neoadjuvant Chemotherapy Does Not Compromise 10-year Breast Cancer Specific Mortality

per Arlow, Renee L, Paddock, Lisa E, Niu, Xiaoling, Kirstein, Laurie, Haffty, Bruce G, Goyal, Sharad, Kearney, Thomas, Toppmeyer, Deborah, Stroup, Antoinette M, Khan, Atif J
Publicat a Am J Clin Oncol (2018)

Amplified Loci on Chromosomes 8 and 17 Predict Early Relapse in ER-Positive Breast Cancers

per Bilal, Erhan, Vassallo, Kristen, Toppmeyer, Deborah, Barnard, Nicola, Rye, Inga H., Almendro, Vanessa, Russnes, Hege, Børresen-Dale, Anne-Lise, Levine, Arnold J., Bhanot, Gyan, Ganesan, Shridar
Publicat 2012

Hypofractionated Postmastectomy Radiation Therapy Is Safe and Effective: First Results From a Prospective Phase II Trial

per Khan, Atif J., Poppe, Matthew M., Goyal, Sharad, Kokeny, Kristine E., Kearney, Thomas, Kirstein, Laurie, Toppmeyer, Deborah, Moore, Dirk F., Chen, Chunxia, Gaffney, David K., Haffty, Bruce G.
Publicat a J Clin Oncol (2017)

Durable Response to PD1 Inhibitor Pembrolizumab in a Metastatic, Metaplastic Breast Cancer

per Gorshein, Elan, Matsuda, Kant, Riedlinger, Gregory, Sokol, Levi, Rodriguez-Rodriguez, Lorna, Eladoumikdachi, Firas, Grandhi, Miral, Ganesan, Shridar, Toppmeyer, Deborah L., Potdevin, Lindsay, Toomey, Kathleen, Hirshfield, Kim M., Chan, Nancy
Publicat a Case Rep Oncol (2021)

Randomized Phase III Trial of Paclitaxel Once Per Week Compared With Nanoparticle Albumin-Bound Nab-Paclitaxel Once Per Week or Ixabepilone With Bevacizumab As First-Line Chemother...

per Rugo, Hope S., Barry, William T., Moreno-Aspitia, Alvaro, Lyss, Alan P., Cirrincione, Constance, Leung, Eleanor, Mayer, Erica L., Naughton, Michael, Toppmeyer, Deborah, Carey, Lisa A., Perez, Edith A., Hudis, Clifford, Winer, Eric P.
Publicat a J Clin Oncol (2015)

SARS‐CoV‐2 nosocomial infection: Real‐world results of environmental surface testing from a large tertiary cancer center

per Shah, Mansi R., Jan, Imraan, Johns, Jeremy, Singh, Kuldip, Kumar, Pallavi, Belarmino, Norma, Saggiomo, Kara J., Hayes, Carolyn, Washington, Kimyatta, Toppmeyer, Deborah L., Haffty, Bruce G., Libutti, Steven K., Evens, Andrew M.
Publicat a Cancer (2021)

Widespread alternative exon usage in clinically distinct subtypes of Invasive Ductal Carcinoma

per Bjørklund, Sunniva Stordal, Panda, Anshuman, Kumar, Surendra, Seiler, Michael, Robinson, Doug, Gheeya, Jinesh, Yao, Ming, Alnæs, Grethe I. Grenaker, Toppmeyer, Deborah, Riis, Margit, Naume, Bjørn, Børresen-Dale, Anne-Lise, Kristensen, Vessela N., Ganesan, Shridar, Bhanot, Gyan
Publicat a Sci Rep (2017)

Quantitative Analysis of BRCA1 and BRCA2 Germline Splicing Variants Using a Novel RNA-Massively Parallel Sequencing Assay

per Farber-Katz, Suzette, Hsuan, Vickie, Wu, Sitao, Landrith, Tyler, Vuong, Huy, Xu, Dong, Li, Bing, Hoo, Jayne, Lam, Stephanie, Nashed, Sarah, Toppmeyer, Deborah, Gray, Phillip, Haynes, Ginger, Lu, Hsiao-Mei, Elliott, Aaron, Tippin Davis, Brigette, Karam, Rachid
Publicat a Front Oncol (2018)

Metabotropic Glutamate Receptor 1 Expression and Its Polymorphic Variants Associate with Breast Cancer Phenotypes

per Mehta, Madhura S., Dolfi, Sonia C., Bronfenbrener, Roman, Bilal, Erhan, Chen, Chunxia, Moore, Dirk, Lin, Yong, Rahim, Hussein, Aisner, Seena, Kersellius, Romona D., Teh, Jessica, Chen, Suzie, Toppmeyer, Deborah L., Medina, Dan J., Ganesan, Shridar, Vazquez, Alexei, Hirshfield, Kim M.
Publicat 2013

Kinetic-Pharmacodynamic Model of Chemotherapy Induced Peripheral Neuropathy in Patients with Metastatic Breast Cancer Treated with Paclitaxel, Nab-Paclitaxel or Ixabepilone: CALGB...

per Mehrotra, Shailly, Sharma, Manish R., Gray, Elizabeth, Wu, Kehua, Barry, William T., Hudis, Clifford, Winer, Eric P., Lyss, Alan P., Toppmeyer, Deborah L., Moreno-Aspitia, Alvaro, Lad, Thomas E., Valasco, Mario, Overmoyer, Beth, Rugo, Hope, Ratain, Mark J., Gobburu, Jogarao V.
Publicat a AAPS J (2017)